Last reviewed · How we verify
NCT04414332: RAPID
Registry of Angiovac Procedures In Detail Outcomes Database-RAPID Registry
trial testing Data collection only in Venous Thromboembolic Disease in 234 participants. Completed in 27 February 2020.
27 February 2020
Quick facts
| Lead sponsor | University of California, Los Angeles |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 234 |
| Start date | 1 September 2015 |
| Primary completion | 27 February 2020 |
| Estimated completion | 27 February 2020 |
Drugs / interventions tested
- Data collection only
Conditions studied
- Venous Thromboembolic Disease — all drugs for Venous Thromboembolic Disease →
- Deep Venous Thrombosis — all drugs for Deep Venous Thrombosis →
- Right Heart Pathology — all drugs for Right Heart Pathology →
- Pulmonary Embolism — all drugs for Pulmonary Embolism →
Sponsor
University of California, Los Angeles
Who can join
18 and older, any sex, with Venous Thromboembolic Disease or Deep Venous Thrombosis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Venous thromboembolic disease is a significant cause of morbidity and mortality. The purpose of the RAPID registry is to collect information on the Angiovac procedure and Angiovac device used in the treatment of deep venous thrombosis (DVT), right heart pathology and pulmonary embolism.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Procedural outcomes associated with use of the AngioVac System for right heart thrombi: A safety report from RAPID registry data.
Moriarty JM, Liao M, Kim GHJ, Yang E, et al · · 2022 · cited 14× · PMID 35176918 · DOI 10.1177/1358863x211073974
Verify or expand the search:
- PubMed search for NCT04414332
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Data collection only
Trials testing the same drug.
- NCT05018507 — Variations in Osteoarthritic Knee Laxity Between Individuals and Populations · completed
Other recruiting trials for Venous Thromboembolic Disease
Currently open trials in the same condition.
- NCT04211181 — CHIPs-VTE Study in Hospitalized Patients to Prevent Hospital-Acquired Venous Thromboembolism · NA · recruiting
- NCT07270263 — Reduced-Dose Apixaban and Rivaroxaban Versus Low-Molecular-Weight Heparin in Patients With Hematologic Malignancies · NA · recruiting
- NCT06232551 — Alerting Providers at Patient Hospital Discharge to Consider Prescribing Rivaroxaban to Reduce Venous Thromboembolism · NA · recruiting
- NCT05396157 — Venous Thromboembolism in Hematologic Malignancy and Hematopoietic Cell Transplant Patients: a Retrospective Study · active not recruiting
- NCT07016542 — Cohort for Monitoring Patients With Venous Thromboembolic Disease · recruiting
Other University of California, Los Angeles trials
Trials by the same sponsor.
- NCT04846517 — rTMS for Aneroxia Nervosa in Youth · NA · not yet recruiting
- NCT06701760 — Sodium Lactate in Severe TBI · Phase 2 · not yet recruiting
- NCT04996667 — Effect of iNO in Patients With Submassive and Massive PE · Phase 2 · withdrawn
- NCT05067387 — Evaluation of Oral THC and CBD in Men and Women · Phase 1 · not yet recruiting
- NCT07534696 — Evaluation of Non-Invasive Pelvic Floor Neuromuscular Stimulation for Urinary Incontinence After Prostatectomy · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04414332 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of California, Los Angeles
- Last refreshed: 4 June 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04414332.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing